Uceris Tablet, Extended Release
Product Images NDC 68012-309

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Uceris (NDC 68012-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Santarus Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

2nd Table

The text appears to be a list of symptoms which include fever, chills, pain, feeling tired, aches, nausea, and vomiting. It suggests that the person experiencing these symptoms may be suffering from an illness or infection, but without additional context or information, it is difficult to determine the exact cause.*

FDA Label Image

Image 01

FDA Label Image

Table 3

This text appears to be a list of different symptoms, including decreased levels of the hormone cortisol, pain in the stomach area, tiredness, gas and bloating, urinary tract infections, joint pain, and constipation. It is possible that these symptoms could be indicative of a medical condition, but without more context it is difficult to determine the exact cause or diagnosis.*

FDA Label Image

Table

This is a list of common symptoms that could indicate an illness or condition. The symptoms include tiredness, vomiting, weakness, and low blood pressure. It is important to consult a healthcare provider if you are experiencing any of these symptoms as they could be a sign of a more serious underlying condition.*

FDA Label Image

Uceris-1.jpg (Uceris 1)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.